{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:00Z","timestamp":1791993840109,"version":"4.4.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"suppl 3","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["R01AI105204"],"award-info":[{"award-number":["R01AI105204"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jefferson Vaccine Center"},{"name":"NIAID Division of Intramural Research, the NIAID Division of Clinical Research"},{"name":"Battelle Memorial Institute's"},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["HHSN272200700016I"],"award-info":[{"award-number":["HHSN272200700016I"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Infect Dis."],"published-print":{"date-parts":[[2016,10,15]]},"DOI":"10.1093\/infdis\/jiw231","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T20:44:23Z","timestamp":1469479463000},"page":"S342-S354","source":"Crossref","is-referenced-by-count":39,"title":["An Inactivated Rabies Virus\u2013Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models"],"prefix":"10.1093","volume":"214","author":[{"given":"Reed F.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drishya","family":"Kurup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie R.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Keshwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Papaneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"ter Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,24]]},"reference":[{"key":"2016120500053903000_214.suppl_3.S342.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6086.541"},{"key":"2016120500053903000_214.suppl_3.S342.2","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola viruses","volume-title":"Fields virology","volume":"Vol 1","author":"Sanchez","year":"2007"},{"key":"2016120500053903000_214.suppl_3.S342.3","unstructured":"Centers for Disease Control and Prevention. 2014 Ebola outbreak in West Africa\u2014outbreak distribution map. Updated 17 March 2016. http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/distribution-map.html. Accessed 31 March 2016."},{"key":"2016120500053903000_214.suppl_3.S342.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60667-8"},{"key":"2016120500053903000_214.suppl_3.S342.5","doi-asserted-by":"publisher","DOI":"10.1089\/bsp.2011.0051"},{"key":"2016120500053903000_214.suppl_3.S342.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092528"},{"key":"2016120500053903000_214.suppl_3.S342.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.314.5805.1522"},{"key":"2016120500053903000_214.suppl_3.S342.8","doi-asserted-by":"publisher","DOI":"10.1126\/science.317.5844.1484"},{"key":"2016120500053903000_214.suppl_3.S342.9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1133105"},{"key":"2016120500053903000_214.suppl_3.S342.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008375"},{"key":"2016120500053903000_214.suppl_3.S342.11","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404792"},{"key":"2016120500053903000_214.suppl_3.S342.12","unstructured":"Centers for Disease Control and Prevention. Sierra Leone trial to introduce a vaccine against Ebola (STRIVE). Updated 20 April 2016. http:\/\/www.cdc.gov\/vhf\/ebola\/strive\/index.html. Accessed 23 May 2016."},{"key":"2016120500053903000_214.suppl_3.S342.13","unstructured":"News N. Ebola Vaccine Trial Opens in Liberia."},{"key":"2016120500053903000_214.suppl_3.S342.14","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.885841"},{"key":"2016120500053903000_214.suppl_3.S342.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003389"},{"key":"2016120500053903000_214.suppl_3.S342.16","doi-asserted-by":"crossref","unstructured":"Marzi A , Feldmann H , Geisbert TW , Falzarano D . Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections. J Bioterror Biodef 2011; pii:2157-2526-S1-004.","DOI":"10.4172\/2157-2526.S1-004"},{"key":"2016120500053903000_214.suppl_3.S342.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.09.030"},{"key":"2016120500053903000_214.suppl_3.S342.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.01.015"},{"key":"2016120500053903000_214.suppl_3.S342.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.024"},{"key":"2016120500053903000_214.suppl_3.S342.20","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.661"},{"key":"2016120500053903000_214.suppl_3.S342.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000904"},{"key":"2016120500053903000_214.suppl_3.S342.22","doi-asserted-by":"publisher","DOI":"10.1038\/nature01876"},{"key":"2016120500053903000_214.suppl_3.S342.23","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2129"},{"key":"2016120500053903000_214.suppl_3.S342.24","doi-asserted-by":"publisher","DOI":"10.1038\/35046108"},{"key":"2016120500053903000_214.suppl_3.S342.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.09.020"},{"key":"2016120500053903000_214.suppl_3.S342.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2237038100"},{"key":"2016120500053903000_214.suppl_3.S342.27","doi-asserted-by":"publisher","DOI":"10.1086\/520583"},{"key":"2016120500053903000_214.suppl_3.S342.28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002600"},{"key":"2016120500053903000_214.suppl_3.S342.29","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir348"},{"key":"2016120500053903000_214.suppl_3.S342.30","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/infdis\/jiv251","article-title":"Preclinical development of inactivated rabies virus-based polyvalent vaccine against rabies and filoviruses","volume":"212(suppl 2)","author":"Willet","year":"2015","journal-title":"J Infect Dis"},{"key":"2016120500053903000_214.suppl_3.S342.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.073"},{"key":"2016120500053903000_214.suppl_3.S342.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.07.020"},{"key":"2016120500053903000_214.suppl_3.S342.33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00558-11"},{"key":"2016120500053903000_214.suppl_3.S342.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404505"},{"key":"2016120500053903000_214.suppl_3.S342.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.09.038"},{"key":"2016120500053903000_214.suppl_3.S342.36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1259657"},{"key":"2016120500053903000_214.suppl_3.S342.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.064"},{"key":"2016120500053903000_214.suppl_3.S342.38","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv284"},{"key":"2016120500053903000_214.suppl_3.S342.39","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv251"},{"key":"2016120500053903000_214.suppl_3.S342.40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02308-14"},{"key":"2016120500053903000_214.suppl_3.S342.41","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/infdis\/jiv251","article-title":"Preclinical development of inactivated rabies virus\u2013based tetravalent vaccine against rabies and filoviruses","volume":"212(suppl 2)","author":"Willet","year":"2015","journal-title":"J Infect Dis"},{"key":"2016120500053903000_214.suppl_3.S342.42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016333"},{"key":"2016120500053903000_214.suppl_3.S342.43","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141855"},{"key":"2016120500053903000_214.suppl_3.S342.44","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.811188"},{"key":"2016120500053903000_214.suppl_3.S342.45","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00235-12"},{"key":"2016120500053903000_214.suppl_3.S342.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.137"},{"key":"2016120500053903000_214.suppl_3.S342.47","doi-asserted-by":"publisher","DOI":"10.3201\/eid2110.150259"},{"key":"2016120500053903000_214.suppl_3.S342.48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61117-5"},{"key":"2016120500053903000_214.suppl_3.S342.49","doi-asserted-by":"publisher","DOI":"10.3201\/eid2201.151410"},{"key":"2016120500053903000_214.suppl_3.S342.50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv532"},{"key":"2016120500053903000_214.suppl_3.S342.51","first-page":"115","article-title":"Antigenic value of lyophilized phenolized antirabies vaccine","volume":"25","author":"Veeraraghavan","year":"1961","journal-title":"Bull World Health Organ"}],"container-title":["Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/214\/suppl_3\/S342\/7936018\/jiw231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T13:43:55Z","timestamp":1568209435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiw231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,24]]},"references-count":51,"journal-issue":{"issue":"suppl 3","published-online":{"date-parts":[[2016,10,5]]},"published-print":{"date-parts":[[2016,10,15]]}},"alternative-id":["10.1093\/infdis\/jiw231"],"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiw231","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,24]]}}}